Skip to main content

Table 9 Safety assessment

From: Effectiveness of the Shenzhuo formula in the treatment of patients with macroalbuminuria secondary to diabetic kidney disease: protocol update and statistical analysis plan

 

0 W

12 W

24 W

SZF

Irbesartan

p value

SZF

Irbesartan

p value

SZF

Irbesartan

p value

(n = xx)

(n = xx)

 

(n = xx)

(n = xx)

 

(n = xx)

(n = xx)

 

Hematology

Red blood cell

xx (xx)

xx (xx)

.xx

xx (xx)

xx (xx)

.xx

xx (xx)

xx (xx)

.xx

 

White blood cell

xx (xx)

xx (xx)

.xx

xx (xx)

xx (xx)

.xx

xx (xx)

xx (xx)

.xx

 

Hemoglobin

xx (xx)

xx (xx)

.xx

xx (xx)

xx (xx)

.xx

xx (xx)

xx (xx)

.xx

 

Platelet

xx (xx)

xx (xx)

.xx

xx (xx)

xx (xx)

.xx

xx (xx)

xx (xx)

.xx

Urine test

Glucose

xx (xx)

xx (xx)

.xx

xx (xx)

xx (xx)

.xx

xx (xx)

xx (xx)

.xx

 

Ketone

xx (xx)

xx (xx)

.xx

xx (xx)

xx (xx)

.xx

xx (xx)

xx (xx)

.xx

 

Occult blood

xx (xx)

xx (xx)

.xx

xx (xx)

xx (xx)

.xx

xx (xx)

xx (xx)

.xx

 

Erythrocytes

xx (xx)

xx (xx)

.xx

xx (xx)

xx (xx)

.xx

xx (xx)

xx (xx)

.xx

 

Leukocytes

xx (xx)

xx (xx)

.xx

xx (xx)

xx (xx)

.xx

xx (xx)

xx (xx)

.xx

Stool routine

Fecal leukocytes

xx (xx)

xx (xx)

.xx

xx (xx)

xx (xx)

.xx

xx (xx)

xx (xx)

.xx

 

Feces occult blood

xx (xx)

xx (xx)

.xx

xx (xx)

xx (xx)

.xx

xx (xx)

xx (xx)

.xx

Liver function

ALT

xx (xx)

xx (xx)

.xx

xx (xx)

xx (xx)

.xx

xx (xx)

xx (xx)

.xx

 

AST

xx (xx)

xx (xx)

.xx

xx (xx)

xx (xx)

.xx

xx (xx)

xx (xx)

.xx

 

ALP

xx (xx)

xx (xx)

.xx

xx (xx)

xx (xx)

.xx

xx (xx)

xx (xx)

.xx

 

GGT

xx (xx)

xx (xx)

.xx

xx (xx)

xx (xx)

.xx

xx (xx)

xx (xx)

.xx

 

TBIL

xx (xx)

xx (xx)

.xx

xx (xx)

xx (xx)

.xx

xx (xx)

xx (xx)

.xx

kidney function

UA

xx (xx)

xx (xx)

.xx

xx (xx)

xx (xx)

.xx

xx (xx)

xx (xx)

.xx

 

β2-microglobulin

xx (xx)

xx (xx)

.xx

xx (xx)

xx (xx)

.xx

xx (xx)

xx (xx)

.xx

 

Serum albumin

xx (xx)

xx (xx)

.xx

xx (xx)

xx (xx)

.xx

xx (xx)

xx (xx)

.xx

 

Blood urea nitrogen

xx (xx)

xx (xx)

.xx

xx (xx)

xx (xx)

.xx

xx (xx)

xx (xx)

.xx

Electrocardiogram

xx (xx%)

xx (xx%)

.xx

xx (xx%)

xx (xx%)

.xx

xx (xx%)

xx (xx%)

.xx

Adverse events

Mild

xx (xx%)

xx (xx%)

.xx

xx (xx%)

xx (xx%)

.xx

xx (xx%)

xx (xx%)

.xx

 

Moderate

xx (xx%)

xx (xx%)

.xx

xx (xx%)

xx (xx%)

.xx

xx (xx%)

xx (xx%)

.xx

 

Severe

xx (xx%)

xx (xx%)

.xx

xx (xx%)

xx (xx%)

.xx

xx (xx%)

xx (xx%)

.xx

 

Overall AEs

xx (xx%)

xx (xx%)

.xx

xx (xx%)

xx (xx%)

.xx

xx (xx%)

xx (xx%)

.xx